Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by dennis001 – Hong Kong, 2022-07-27 07:21 (776 d 12:46 ago) – Posting: # 23181
Views: 2,725

Dear ElMaestro
Thanks!

❝ Clearly a case for an NI trial one way or another.


Thank you for your comment that helped to assuage my doubts.

❝ Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.


Ok. we will discuss with them.

Complete thread:

UA Flag
Activity
 Admin contact
23,223 posts in 4,877 threads, 1,656 registered users;
42 visitors (0 registered, 42 guests [including 8 identified bots]).
Forum time: 20:08 CEST (Europe/Vienna)

Explanations exist; they have existed for all time;
there is always an easy solution to every human problem –
neat, plausible and wrong.    H. L. Mencken

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5